Trial intelligence / Profile preview

Varenicline Adjunctive Treatment in Schizophrenia

NCT00492349Phase 4Completed

Sponsor
University of Maryland, Baltimore
Start
May 2007
Primary completion
May 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of varenicline in schizophrenia, schizoaffective disorder, schizophreniform disorder, sponsored by University of Maryland, Baltimore. Started May 2007; status: completed.

02

Drugs

varenicline
03

Conditions

schizophreniaschizoaffective disorderschizophreniform disorder

Beyond the preview

Go deeper on NCT00492349.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00492349.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call